In fact, as previously mentioned, early-stage cancers have been reported to exhibit a loss or downregulation of Cx43 and GJIC activity; thus, restoring Cx43 expression and GJIC was undertaken as a treatment approach [14]. Here, GJA1 is linked to cancer.